XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls

BACKGROUND: Previous studies have investigated the correlation between xeroderma pigmentosumcomplementation group C (XPC) variants and prostate adenocarcinoma (PA) risk. Nevertheless, research findings remain inconclusive. METHODS: We conducted a pooled analysis to obtain a more accurate estimation...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Main Authors: Qin, Feng, Gao, Sheng-Lin, Xu, Kai, Su, Quan-Xin, Zhang, Ze, Shi, Li, Zhu, Li-Jie, Zhang, Li-Feng, Zuo, Li
Formato: Artigo
Idioma:Inglês
Publicado: Wolters Kluwer Health 2020
Assuntos:
7300
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7360297/
https://ncbi.nlm.nih.gov/pubmed/32664151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000021160
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares